Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;101(4):1024-8.
doi: 10.1111/j.1349-7006.2009.01482.x. Epub 2010 Feb 22.

Immunohistochemical analysis of CYP2A13 in various types of human lung cancers

Affiliations

Immunohistochemical analysis of CYP2A13 in various types of human lung cancers

Tatsuki Fukami et al. Cancer Sci. 2010 Apr.

Abstract

Human CYP2A13, which is expressed in the respiratory tract, is the most efficient enzyme for the metabolic activation of tobacco-specific nitrosamines such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The relevance of CYP2A13 in carcinogenicity and toxicity in the respiratory tract has been suggested, but the expression of CYP2A13 protein in lung cancer tissues remains to be determined. We first prepared a mouse monoclonal antibody against human CYP2A13. The antibody showed no cross reactivity with the other CYP isoforms including CYP2A6. Using the specific antibody, we performed immunohistochemical analysis for human lung carcinomas. In adenocarcinomas (n = 15), all specimens were positive for the staining and five samples showed strong staining. In squamous cell carcinomas (n = 15) and large cell carcinomas (n = 15), each 14 samples were positive for the staining and two and three samples showed strong staining, respectively. In small cell carcinoma samples (n = 15), eight samples were negative for the staining and five samples showed weak or moderate staining. In conclusion, we first found that the expression of CYP2A13 was markedly increased in non-small cell lung carcinomas. The high expression might be associated with the tumor development and progression in non-small cell lung carcinomas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunoblot analysis using the mouse monoclonal antibody against human CYP2A13 prepared in this study. One pmol each of recombinant P450 isoforms, CYP1A1, CYP1B1, CYP2B6, CYP2D6, CYP2E1, and CYP3A4 expressed in baculovirus‐infected insect cells and CYP2A6, CYP2A13, and CYP2S1 expressed in E. coli, were separated on 10% SDS‐PAGE.
Figure 2
Figure 2
Immunohistochemical analysis of CYP2A13 in human lung cancer tissues. Adjacent noncancerous (a) bronchus and (b) peripheral lung tissues; (c) adenocarcinoma; (d) squamous cell carcinoma; (e) large cell carcinoma; (f) small cell carcinoma. Strong immunostaining was observed in the epithelial cells in bronchus, but not in peripheral lung tissues. In lung carcinomas, immunostaining was positive in most of non‐small cell carcinomas. In contrast, the staining was mostly negative in small cell carcinoma. Original mag‐nification, ×200.

Similar articles

Cited by

References

    1. Fernandez‐Salguero P, Hoffman SMG, Cholerton S et al. A genetic polymorphism in coumarin 7‐hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 1995; 57: 651–60. - PMC - PubMed
    1. Yamano S, Tatsuno J, Gonzalez FJ. The CYP2A3 gene product catalyzes coumarin 7‐hydroxylation in human liver microsomes. Biochemistry 1990; 29: 1322–9. - PubMed
    1. Su T, Bao Z, Zhang QY et al. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco‐specific carcinogen, 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone. Cancer Res 2000; 60: 5074–9. - PubMed
    1. Koskela S, Hakkola J, Hukkanen J et al. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 1999; 57: 1407–13. - PubMed
    1. Gu J, Su Y, Chen QY et al. Expression and biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. Toxicol Appl Pharmacol 2000; 165: 158–62. - PubMed

MeSH terms

Substances